Manufacturer record

Nikvin Healthcare (I) Pvt Ltd: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

4 batches manufactured by Nikvin Healthcare (I) Pvt Ltd (Himachal Pradesh) were declared Not of Standard Quality between December 2019 and August 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: CT503513C, Cefuroxime Axetil IP (exp Feb 2027). DTL, Bengaluru, Karnataka (state lab) found it not of standard quality: Description. Listed in the August 2026 alert.

Records by type

4 records linked to Nikvin Healthcare (I) Pvt Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
4Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Dec 2019 to Aug 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

4
NSQ batches since 2019
3
Products affected
Dissolution
Most common failure
Aug 2026
Latest alert

Flagged batches per year

2019 · 12025 · 22026 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Cefuroxime Axetil IP Batch CT503513CMfg Mar 2025 · Exp Feb 2027 DescriptionDescription DTL, Bengaluru, KarnatakaState lab Aug 2026
Amoxycillin and potassium clavulanate tablets IP (AUGMONT CV 625 DUP Co- amoxiclav) Batch BT408244AMfg Aug 2024 · Exp Apr 2026 Sample does not conform to IP specification for amoxycillin and potassium clavulanate tablets with respect to the content of Clavulanic acid in potassium clavulanate.Other DTL MaduraiState lab Apr 2025
Amoxycillin & Potassium Calvulanate Tablets Batch BT406210AMfg Jun 2024 · Exp May 2026 Sample does not conform to IP specification for Amoxycillin and Potassium Clavulanate Tablets with respect to Dissolution for Clavulanic Acid and to the content of Clavulanic Acid in Potassium Clavulanate DilutedDissolution DTL ChennaiState lab Apr 2025
Cefuroxime Axetil Tablets I.P. 500mg. (Amytum-500) Batch C903701TMfg Mar 2019 · Exp Feb 2021 DissolutionDissolution RDTL GuwahatiState lab Dec 2019

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.